Attached files

file filename
8-K - FORM 8-K - FLOWERS FOODS INCd91758d8k.htm

Exhibit 99.1

 

LOGO

Company Press Release

 

November 5, 2020

 

Flowers Foods (NYSE: FLO)

FLOWERS FOODS, INC. REPORTS THIRD QUARTER 2020 RESULTS

THOMASVILLE, Ga. – Flowers Foods, Inc. (NYSE: FLO), producer of Nature’s Own, Dave’s Killer Bread, Wonder, Tastykake, and other bakery foods, today reported financial results for the company’s 12-week third quarter ended October 3, 2020.

Third Quarter Summary:

Compared to the prior year third quarter where applicable

 

   

Sales increased 2.4% to $989.7 million.

 

   

Net income increased 2.3% to $44.3 million. Adjusted net income increased 36.3% to $62.4 million.

 

   

Adjusted EBITDA(1) increased 22.4% to $116.4 million, representing 11.8% of sales, a 200-basis point increase.

 

   

Diluted EPS increased $0.01 to $0.21. Adjusted diluted EPS(1) increased $0.07 to $0.29.

 

  (1)

Adjusted for items affecting comparability. See reconciliations of non-GAAP measures in the financial statements following this release.

CEO’s Remarks:

“Our record third quarter reflects a favorable operating environment for our branded retail business and our continued focus on achieving our strategic priorities,” said Ryals McMullian, Flowers Foods’ president and CEO. “The impact of the COVID-19 pandemic persisted in the third quarter, though at more moderate levels than in the second quarter. Our team continues to perform exceptionally well in this unprecedented environment and I am proud of their resiliency as they continue to serve our markets.”

“We are capitalizing on the increased frequency of in-home eating, which has driven elevated trial of our market-leading products, by executing on our portfolio strategy and supply chain optimization initiatives,” he continued. “We expect the demand environment to continue to moderate, but we believe our focus on product quality, innovation, and marketing will allow us to retain many of these new consumers and drive improved sales growth and margin expansion in support of our long-term growth targets.”


McMullian added, “We remain confident in our ability to deliver at least $20 million of cost savings this year and are working tirelessly to drive even more efficiencies. With our organizational restructuring and portfolio and supply chain optimization initiatives, we are becoming a more branded-focused company, which will ultimately boost our ability to drive shareholder value.”

For the 53-week Fiscal 2020, the Company Expects:

 

   

Sales in the range of approximately $4.350 billion to $4.370 billion, representing growth of approximately 5.5% to 6.0%.

 

   

Diluted EPS in the range of approximately $0.65 to $0.70.

 

   

Adjusted diluted EPS in the range of approximately $1.23 to $1.28, adjusted for items affecting comparability, representing annual growth of approximately 28.1% to 33.3%.

The company’s outlook includes the following assumptions:

 

   

Portfolio and supply chain optimization benefit in excess of $20 million

 

   

Depreciation and amortization in the range of $140 million to $145 million

 

   

Net interest expense of approximately $11 million

 

   

An effective tax rate of approximately 24.0% to 24.5%

 

   

Weighted average diluted share count for the year of approximately 212.5 million shares

 

   

Capital expenditures for the year in the range of $85 million to $95 million

Matters Affecting Comparability:

Reconciliation of Earnings per Share to Adjusted Earnings per Share

 

     For the 12 Weeks Ended  
     Oct. 3, 2020      Oct. 5, 2019  

Net income per diluted common share

   $ 0.21      $  0.20  

Restructuring and related impairment charges

     0.07        0.01  

Project Centennial consulting costs

     0.02        —    

ERP road mapping consulting costs

     0.01        —    

Legal settlements

     0.01        —    

Pension plan settlement gain

     (0.03      —    
  

 

 

    

 

 

 

Adjusted net income per diluted common share

   $ 0.29      $ 0.22  
  

 

 

    

 

 

 

Certain amounts may not compute due to rounding.


Consolidated Third Quarter Operating Highlights

Compared to the prior year third quarter where applicable

 

   

Sales increased 2.4% to $989.7 million.

 

   

Percentage point change in sales attributed to:

 

   

Pricing/mix: 8.1%, primarily driven by mix

 

   

Volume: -5.7%

 

   

Branded retail sales increased $71.2 million or 12.2% to $657.1 million, store branded retail sales decreased $14.4 million or 9.5% to $136.6 million, while non-retail and other sales decreased $33.7 million or 14.7% to $196.0 million.

 

   

Branded retail sales increased due to the impact of the COVID-19 pandemic, new product introductions, lower promotional activity, and a reduction in product returns.

 

   

Store branded retail sales decreased primarily due to volume declines as consumer purchasing shifted to branded retail products, partly offset by improved price/mix.

 

   

Non-retail and other sales declined primarily due to the impact of the pandemic on foodservice customers.

 

   

Net income increased 2.3% to $44.3 million. Adjusted net income increased 36.3% to $62.4 million.

 

   

Adjusted EBITDA increased 22.4% to $116.4 million, representing 11.8% of sales, a 200-basis point increase.

 

   

Materials, supplies, labor and other production costs (exclusive of depreciation and amortization) were 50.3% of sales, a 240-basis point decrease. These costs were lower as a percentage of sales due to positive shifts in mix from non-retail and store branded retail products to branded retail products. Ingredient and packaging costs declined due to the mix shift and lower product returns.

 

   

Selling, distribution and administrative (SD&A) expenses were 39.1% of sales, a 160-basis point increase. Excluding matters affecting comparability, adjusted SD&A expenses were 38.0% of sales, a 50-basis point increase. Higher employee incentive costs and an increase in distributor distribution fees due to a shift in product mix were the primary drivers of the increased costs. Partially offsetting the higher costs were lower logistics expenses related to the product mix shift, lower fuel costs, and the benefit of supply chain optimization projects.

 

   

Depreciation and amortization (D&A) expenses were $32.2 million, or 3.2% of sales, a 20-basis point decrease.

Cash Flow, Capital Allocation, and Capital Return

Year-to-date, through the third quarter of fiscal 2020, cash flow from operating activities increased by $86.3 million to $364.4 million, capital expenditures decreased $2.3 million to $68.3 million, and dividends paid increased $5.1 million to $124.9 million. There were no debt borrowings or repayments in the quarter. Cash and cash equivalents were $325.8 million at quarter-end.


There are 6.2 million shares authorized for repurchase under the company’s current share repurchase plan. The company expects to continue to make opportunistic share repurchases from time to time under this plan.

Pre-Recorded Management Remarks and Question and Answer Webcast

In conjunction with this release, Flowers Foods will post pre-recorded management remarks and a supporting slide presentation to its website. The company will host a live question and answer webcast at 8:30 a.m. (Eastern) on November 6, 2020. The pre-recorded remarks and the webcast can be accessed at flowersfoods.com/investors and will be archived on the company’s website.

About Flowers Foods

Headquartered in Thomasville, Ga., Flowers Foods, Inc. (NYSE: FLO) is one of the largest producers of packaged bakery foods in the United States with 2019 sales of $4.1 billion. Flowers operates bakeries across the country that produce a wide range of bakery products. Among the company’s top brands are Nature’s Own, Dave’s Killer Bread, Wonder, and Tastykake. Learn more at www.flowersfoods.com.

Investor Contact: J.T. Rieck (229) 227-2253

Media Contact: Paul Baltzer (229) 227-2380

Forward-Looking Statements

Statements contained in this press release that are not historical facts are forward-looking statements. Forward-looking statements relate to current expectations regarding our future financial condition, performance and results of operations and the ultimate impact of the novel strain of coronavirus (COVID-19) pandemic on our business, results of operations and financial condition, planned capital expenditures, long-term objectives of management, supply and demand, pricing trends and market forces, and integration plans and expected benefits of transactions and are often identified by the use of words and phrases such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” “will,” “would,” “is likely to,” “is expected to” or “will continue,” or the negative of these terms or other comparable terminology. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ from those projected. Other factors that may cause actual results to differ from the forward-looking statements contained in this release and that may affect the company’s prospects in general include, but are not limited to, (a) the ultimate impact of the COVID-19 pandemic and measures taken in response thereto, including, among other things, temporary or ongoing bakery closures, on our business, results of operations and financial condition, which are highly uncertain and are difficult to predict, (b) general economic and business conditions and the competitive conditions in the baked foods industry, including promotional and price competition, (c) changes in consumer demand for our products, including changes in consumer behavior, trends and preferences, including health and whole grain trends, and the movement toward more inexpensive store-branded products, (d) the success of


productivity improvements and new product introductions, (e) a significant reduction in business with any of our major customers including a reduction from adverse developments in any of our customer’s business, (f) fluctuations in commodity pricing, (g) energy and raw material costs and availability and hedging and counterparty risk, (h) our ability to fully integrate recent acquisitions into our business, (i) our ability to achieve cash flow from capital expenditures and acquisitions and the availability of new acquisitions that build shareholder value, (j) our ability to successfully implement our business strategies, including those strategies the company has initiated under Project Centennial, which may involve, among other things, the deployment of new systems and technology and an enhanced organizational structure; (k) our ability to integrate recent acquisitions or the acquisition or disposition of assets at presently targeted values, (l) consolidation within the baking industry and related industries, (m) disruptions in our direct-store delivery system, including litigation or an adverse ruling from a court or regulatory or government body that could affect the independent contractor classification of our independent distributors, (n) increasing legal complexity and legal proceedings that we are or may become subject to, (o) product recalls or safety concerns related to our products, and (p) the failure of our information technology systems to perform adequately, including any interruptions, intrusions or security breaches of such systems or risks associated with the planned implementation of a new enterprise resource planning system. The foregoing list of important factors does not include all such factors, nor necessarily present them in order of importance. In addition, you should consult other public disclosures made by the company, including the risk factors included in our most recently filed Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (“SEC”) and disclosures made in other filings with the SEC and company press releases, for other factors that may cause actual results to differ materially from those projected by the company. We caution you not to place undue reliance on forward-looking statements, as they speak only as of the date made and are inherently uncertain. The company undertakes no obligation to publicly revise or update such statements, except as required by law.

Information Regarding Non-GAAP Financial Measures

The company prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP). However, from time to time, the company may present in its public statements, press releases and SEC filings, non-GAAP financial measures such as, EBITDA, adjusted EBITDA, adjusted EBIT, EBITDA margin, adjusted EBITDA margin, adjusted net income, adjusted operating income, adjusted EPS, adjusted income tax expense, adjusted selling, distribution and administrative expenses (SD&A), gross margin excluding depreciation and amortization, free cash flow, and the ratio of net debt to adjusted EBITDA. The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure. The company’s definitions of these non-GAAP measures may differ from similarly titled measures used by others. These non-GAAP measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.


The company defines EBITDA earnings before interest, taxes, depreciation and amortization. The company defines free cash flow as operating cash flow minus capital expenditures. The company believes that free cash flow provides investors a better understanding of the company’s liquidity position. The company believes that EBITDA is a useful tool for managing the operations of its business and is an indicator of the company’s ability to incur and service indebtedness and generate free cash flow. EBITDA is used as the primary performance measure in the company’s 2014 Omnibus Equity and Incentive Compensation Plan. Furthermore, pursuant to the terms of our credit facility, EBITDA is used to determine the company’s compliance with certain financial covenants. The company also believes that EBITDA measures are commonly reported and widely used by investors and other interested parties as measures of a company’s operating performance and debt servicing ability because EBITDA measures assist in comparing performance on a consistent basis without regard to depreciation or amortization, which can vary significantly depending upon accounting methods and non-operating factors (such as historical cost). EBITDA is also a widely-accepted financial indicator of a company’s ability to incur and service indebtedness.

EBITDA should not be considered an alternative to (a) income from operations or net income (loss) as a measure of operating performance; (b) cash flows provided by operating, investing and financing activities (as determined in accordance with GAAP) as a measure of the company’s ability to meet its cash needs; or (c) any other indicator of performance or liquidity that has been determined in accordance with GAAP.

The company defines adjusted EBITDA, adjusted EBIT, EBITDA margin, adjusted EBITDA margin, adjusted net income, adjusted operating income, adjusted EPS, adjusted income tax expense, adjusted SD&A, respectively, excluding the impact of asset impairment charges, Project Centennial consulting costs, lease terminations and legal settlements, acquisition-related costs, and pension plan settlements. Adjusted income tax expense also excludes the impact of tax reform. The company believes that these measures, when considered together with its GAAP financial results, provides management and investors with a more complete understanding of its business operating results, including underlying trends, by excluding the effects of certain charges.

The company defines net debt as total debt less cash and cash equivalents. Net debt to EBITDA is used as a measure of financial leverage employed by the company. Gross margin excluding depreciation and amortization is used as a performance measure to provide additional transparent information regarding our results of operations on a consolidated and segment basis. Changes in depreciation and amortization are separately discussed and include depreciation and amortization for materials, supplies, labor and other production costs and operating activities.

Presentation of gross margin includes depreciation and amortization in the materials, supplies, labor and other production costs according to GAAP. Our method of presenting gross margin excludes the depreciation and amortization components, as discussed above.

The reconciliations attached provide reconciliations of the non-GAAP measures used in this presentation or release to the most comparable GAAP financial measure.


Flowers Foods, Inc.

Condensed Consolidated Balance Sheets

 

(000’s omitted)

 

     October 3, 2020      December 28, 2019  

Assets

     

Cash and Cash Equivalents

   $ 325,831      $ 11,044  

Other Current Assets

     512,521        515,165  

Property, Plant & Equipment, net

     694,450        717,822  

Right-of-Use Leases, net

     353,400        399,302  

Distributor Notes Receivable (1)

     210,352        226,348  

Other Assets

     20,676        12,644  

Cost in Excess of Net Tangible Assets, net

     1,268,238        1,295,451  
  

 

 

    

 

 

 

Total Assets

   $ 3,385,468      $ 3,177,776  
  

 

 

    

 

 

 

Liabilities and Stockholders’ Equity

     

Current Liabilities

   $ 459,107      $ 463,431  

Long-term Debt (2)

     1,009,839        866,508  

Right-of-Use Lease Liabilities (3)

     372,364        404,503  

Other Liabilities

     192,672        179,904  

Stockholders’ Equity

     1,351,486        1,263,430  
  

 

 

    

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 3,385,468      $ 3,177,776  
  

 

 

    

 

 

 

 

(1)

Includes current portion of $28,291 and $27,709, respectively.

(2)

Includes current portion of $0 and $3,730, respectively.

(3)

Includes current portion of $57,176 and $60,982, respectively.


Flowers Foods, Inc.

Consolidated Statement of Operations

 

(000’s omitted, except per share data)

 

     For the 12 Week
Period Ended
    For the 12 Week
Period Ended
     For the 40 Week
Period Ended
    For the 40 Week
Period Ended
 
     October 3, 2020     October 5, 2019      October 3, 2020     October 5, 2019  

Sales

   $ 989,650     $ 966,561      $ 3,364,955     $ 3,206,215  

Materials, supplies, labor and other production costs (exclusive of depreciation and amortization shown separately below)

     497,659       509,056        1,674,565       1,669,749  

Selling, distribution and administrative expenses

     386,739       362,380        1,305,678       1,197,926  

Recovery on inferior ingredients

     —         —          —         (413

Restructuring and related impairment charges

     20,100       3,277        30,635       6,042  

Depreciation and amortization expense

     32,162       33,196        110,005       111,344  
  

 

 

   

 

 

    

 

 

   

 

 

 

Income from operations

     52,990       58,652        244,072       221,567  

Other pension (benefit) cost

     (72     518        (1     1,729  

Pension plan settlement and curtailment (gain) loss

     (7,153     —          109,054       —    

Interest expense, net

     2,755       2,334        8,938       8,927  
  

 

 

   

 

 

    

 

 

   

 

 

 

Income before income taxes

     57,460       55,800        126,081       210,911  

Income tax expense

     13,113       12,442        29,587       48,592  
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income

   $ 44,347     $ 43,358      $ 96,494     $ 162,319  
  

 

 

   

 

 

    

 

 

   

 

 

 

Net income per diluted common share

   $ 0.21     $ 0.20      $ 0.45     $ 0.77  
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted weighted average shares outstanding

     212,458       212,014        212,270       211,956  
  

 

 

   

 

 

    

 

 

   

 

 

 


Flowers Foods, Inc.

Condensed Consolidated Statement of Cash Flows

 

(000’s omitted)

 

     For the 12 Week
Period Ended
    For the 12 Week
Period Ended
    For the 40 Week
Period Ended
    For the 40 Week
Period Ended
 
     October 3, 2020     October 5, 2019     October 3, 2020     October 5, 2019  

Cash flows from operating activities:

        

Net income

   $ 44,347     $ 43,358     $ 96,494     $ 162,319  

Adjustments to reconcile net income to net cash from operating activities:

        

Total non-cash adjustments

     40,622       42,449       234,135       140,018  

Changes in assets and liabilities and pension contributions

     3,673       (15,764     33,807       (24,237
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     88,642       70,043       364,436       278,100  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

        

Purchase of property, plant and equipment

     (21,676     (23,198     (68,270     (70,610

Proceeds from sale of property, plant and equipment

     248       2,005       1,700       2,548  

Other

     4,620       1,831       13,983       2,956  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash disbursed for investing activities

     (16,808     (19,362     (52,587     (65,106
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Dividends paid

     (42,320     (40,189     (124,948     (119,799

Payment of contingent consideration

     —         —         (4,700     —    

Stock repurchases

     —         —         (783     (7,054

Net change in debt borrowings

     —         (15,750     142,500       (102,500

Payments on financing leases

     (2,593     (1,682     (6,493     (4,985

Other

     (652     4,139       (2,638     3,006  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (disbursed for) provided by financing activities

     (45,565     (53,482     2,938       (231,332
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

     26,269       (2,801     314,787       (18,338

Cash and cash equivalents at beginning of period

     299,562       9,769       11,044       25,306  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 325,831     $ 6,968     $ 325,831     $ 6,968  
  

 

 

   

 

 

   

 

 

   

 

 

 


Flowers Foods, Inc.

Sales by Sales Class and Sales Bridge

(000’s omitted)

 

Sales by Sales Class

         For the 12 Week      
Period Ended
     For the 12 Week Period
Ended
              
     October 3, 2020      October 5, 2019                $ Change               % Change  

Branded Retail

   $ 657,050      $ 585,844      $ 71,206       12.2

Store Branded Retail

     136,639        151,057        (14,418     -9.5

Non-Retail and Other

     195,961        229,660        (33,699     -14.7
  

 

 

    

 

 

    

 

 

   

Total Sales

   $ 989,650      $ 966,561      $ 23,089       2.4
  

 

 

    

 

 

    

 

 

   

Sales by Sales Class

   For the 40 Week
Period Ended
     For the 40 Week Period
Ended
              
     October 3, 2020      October 5, 2019      $ Change     % Change  

Branded Retail

   $ 2,236,301      $ 1,928,500      $ 307,801       16.0

Store Branded Retail

     472,238        505,388        (33,150     -6.6

Non-Retail and Other

     656,416        772,327        (115,911     -15.0
  

 

 

    

 

 

    

 

 

   

Total Sales

   $ 3,364,955      $ 3,206,215      $ 158,740       5.0
  

 

 

    

 

 

    

 

 

   

Sales Bridge

 

For the 12 Week Period Ended October 3, 2020

   Volume     Net
Price/Mix
    Total
Sales Change
 

Flowers Foods

     -5.7     8.1     2.4

Sales Bridge

 

           Net     Total  

For the 40 Week Period Ended October 3, 2020

   Volume     Price/Mix     Sales Change  

Flowers Foods

     -2.5     7.5     5.0


Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

 

(000’s omitted, except per share data)

 

     Reconciliation of Earnings per Share to Adjusted Earnings per Share  
     For the 12 Week
Period Ended
     For the 12 Week
Period Ended
     For the 40 Week
Period Ended
     For the 40 Week
Period Ended
 
     October 3, 2020      October 5, 2019      October 3, 2020      October 5, 2019  

Net income per diluted common share

   $ 0.21      $ 0.20      $ 0.45      $ 0.77  

Recovery on inferior ingredients

     —          —          —          NM  

Restructuring and related impairment charges

     0.07        0.01        0.11        0.02  

Project Centennial consulting costs

     0.02        —          0.05        —    

ERP road mapping consulting costs

     0.01        —          0.01        —    

Legal settlements (recovery)

     0.01        —          0.02        NM  

Executive retirement agreement

     —            —          —          NM  

Canyon acquisition costs

     —          —          —          NM  

Pension plan settlement and curtailment (gain) loss

     (0.03      —          0.39        —    

Other pension plan termination costs

     —          —          NM        —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted net income per diluted common share

   $ 0.29      $ 0.22      $ 1.03      $ 0.78  
  

 

 

    

 

 

    

 

 

    

 

 

 
NM - not meaningful.            
Certain amounts may not add due to rounding.

 

        

 

     Reconciliation of Gross Margin  
     For the 12 Week
Period Ended
     For the 12 Week
Period Ended
     For the 40 Week
Period Ended
     For the 40 Week
Period Ended
 
     October 3, 2020      October 5, 2019      October 3, 2020      October 5, 2019  

Sales

   $ 989,650      $ 966,561      $ 3,364,955      $ 3,206,215  

Materials, supplies, labor and other production costs (exclusive of depreciation and amortization)

     497,659        509,056        1,674,565        1,669,749  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross Margin excluding depreciation and amortization

     491,991        457,505        1,690,390        1,536,466  

Less depreciation and amortization for production activities

     17,443        18,454        59,814        62,022  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross Margin

   $ 474,548      $ 439,051      $ 1,630,576      $ 1,474,444  
  

 

 

    

 

 

    

 

 

    

 

 

 

Depreciation and amortization for production activities

   $ 17,443      $ 18,454      $ 59,814      $ 62,022  

Depreciation and amortization for selling, distribution and administrative activities

     14,719        14,742        50,191        49,322  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total depreciation and amortization

   $ 32,162      $ 33,196      $ 110,005      $ 111,344  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Reconciliation of Selling, Distribution and Administrative Expenses to
Adjusted SD&A
 
     For the 12 Week
Period Ended
     For the 12 Week
Period Ended
     For the 40 Week
Period Ended
     For the 40 Week
Period Ended
 
     October 3, 2020      October 5, 2019      October 3, 2020      October 5, 2019  

Selling, distribution and administrative expenses (SD&A)

   $ 386,739      $ 362,380      $ 1,305,678      $ 1,197,926  

Project Centennial consulting costs

     (5,068      —          (14,044      —    

ERP road mapping consulting costs

     (3,079      —          (3,079      —    

Legal (settlements) recovery

     (3,011      —          (6,231      1,136  

Executive retirement agreement

     —          —          —          (763

Canyon acquisition costs

     —          —          —          (22

Other pension plan termination costs

     —          —          (133      —    
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted SD&A

   $ 375,581      $ 362,380      $ 1,282,191      $ 1,198,277  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     Reconciliation of Net Income to EBITDA and Adjusted EBITDA  
     For the 12 Week
Period Ended
    For the 12 Week
Period Ended
    For the 40 Week
Period Ended
    For the 40 Week
Period Ended
 
     October 3, 2020     October 5, 2019     October 3, 2020     October 5, 2019  

Net income

   $ 44,347     $ 43,358     $ 96,494     $ 162,319  

Income tax expense

     13,113       12,442       29,587       48,592  

Interest expense, net

     2,755       2,334       8,938       8,927  

Depreciation and amortization

     32,162       33,196       110,005       111,344  
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA

     92,377       91,330       245,024       331,182  

Other pension (benefit) cost

     (72     518       (1     1,729  

Pension plan settlement and curtailment (gain) loss

     (7,153     —         109,054       —    

Other pension plan termination costs

     —         —         133       —    

Recovery on inferior ingredients

     —         —         —         (413

Restructuring and related impairment charges

     20,100       3,277       30,635       6,042  

Project Centennial consulting costs

     5,068       —         14,044       —    

ERP road mapping consulting costs

     3,079       —         3,079       —    

Legal settlements (recovery)

     3,011       —         6,231       (1,136

Executive retirement agreement

     —         —         —         763  

Canyon acquisition costs

     —         —         —         22  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 116,410     $ 95,125     $ 408,199     $ 338,189  
  

 

 

   

 

 

   

 

 

   

 

 

 

Sales

   $ 989,650     $ 966,561     $ 3,364,955     $ 3,206,215  

Adjusted EBITDA margin

     11.8     9.8     12.1     10.5
  

 

 

   

 

 

   

 

 

   

 

 

 


Flowers Foods, Inc.

Reconciliation of GAAP to Non-GAAP Measures

 

(000’s omitted, except per share data)

 

     Reconciliation of Income Tax Expense to Adjusted Income Tax Expense  
     For the 12 Week
Period Ended
         For the 12 Week
Period Ended
            For the 40 Week
Period Ended
            For the 40 Week
Period Ended
 
     October 3, 2020          October 5, 2019             October 3, 2020             October 5, 2019  

Income tax expense

   $  13,113        $  12,442         $ 29,587         $ 48,592  

Tax impact of:

                   

Recovery on inferior ingredients

     —            —             —             (104

Restructuring and related impairment charges

     5,025          828                    7,659                    1,526  

Project Centennial consulting costs

     1,267          —             3,511           —    

ERP road mapping consulting costs

     770          —             770           —    

Legal settlements (recovery)

     753          —             1,558           (287

Executive retirement agreement

     —            —             —             193  

Canyon acquisition costs

     —            —             —             6  

Pension plan settlement and curtailment (gain) loss

     (1,788        —             27,264           —    

Other pension plan termination costs

     —            —             33           —    
  

 

 

      

 

 

       

 

 

       

 

 

 

Adjusted income tax expense

   $ 19,140        $ 13,270         $ 70,382         $ 49,926  
  

 

 

      

 

 

       

 

 

       

 

 

 
     Reconciliation of Net Income to Adjusted Net Income  
     For the 12 Week
Period Ended
         For the 12 Week
Period Ended
            For the 40 Week
Period Ended
            For the 40 Week
Period Ended
 
     October 3, 2020          October 5, 2019             October 3, 2020             October 5, 2019  

Net income

   $ 44,347        $ 43,358         $ 96,494         $  162,319  

Recovery on inferior ingredients

     —            —             —             (309

Restructuring and related impairment charges

     15,075          2,449           22,976           4,516  

Project Centennial consulting costs

     3,801          —             10,533           —    

ERP road mapping consulting costs

     2,309          —             2,309           —    

Legal settlements (recovery)

     2,258          —             4,673           (849

Executive retirement agreement

     —            —             —             570  

Canyon acquisition costs

     —            —             —             16  

Pension plan settlement and curtailment (gain) loss

     (5,365        —             81,790           —    

Other pension plan termination costs

     —            —             100           —    
  

 

 

      

 

 

       

 

 

       

 

 

 

Adjusted net income

   $ 62,425        $ 45,807         $  218,875         $ 166,263  
  

 

 

      

 

 

       

 

 

       

 

 

 
     Reconciliation of Earnings per Share - Full Year
Fiscal 2020 Guidance
                             
     Range Estimate  

Net income per diluted common share

   $  0.65     to    $  0.70  

Restructuring and related impairment charges

     0.11          0.11  

Project Centennial consulting costs

     0.05          0.05  

ERP road mapping consulting costs

     0.01          0.01  

Legal settlements

     0.02          0.02  

Pension plan settlement and curtailment loss

     0.39          0.39  

Other pension plan termination costs

     NM          NM  
  

 

 

      

 

 

 

Adjusted net income per diluted common share

   $ 1.23      to    $ 1.28  
  

 

 

      

 

 

 

Certain amounts may not add due to rounding.